Thyme Care shared on LinkedIn:
“Thyme Care was built with a physician at the table from day one.
Medical oncologist Bobby Green, M.D. co-founded this company, and now Brad Diephuis, a primary care physician, is stepping into the CEO role alongside him.
That puts clinicians at the center of everything we do, from the strategy that shapes the company to the care that reaches people between visits.
And that’s by design.
Because cancer care doesn’t break down during the appointment.
It breaks down in the spaces between, when a patient is home, unsure if what they’re feeling is ‘normal’, and not having a system designed to support them in those moments.
Fixing that takes people who understand oncology from the inside.
That clinical foundation is what makes our whole model work:
- It earns the deep integration into oncology practices that lets us extend their reach and support patients outside the clinic.
- It keeps every decision anchored in what patients actually experience, not just what happens in the doctor’s office.
It’s the foundation we’re building on.
As Thyme Care scales its core business, Robin Shah is turning to the problems that still fall between stakeholders, like drug affordability and clinical trial access.
Our leadership architecture is designed to support this moment, because we believe that the next era of oncology will be defined by how well the ecosystem works together on behalf of the patient.
Thank you OncoDaily for covering the news.”
Brad Diephuis Named CEO of Thyme Care as Robin Shah Becomes Executive Chairman
Other articles about Thyme Care, Bobby Green and Brad Diephuis on OncoDaily.